This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.

KEYTRUDA® (pembrolizumab) KEYNOTE-054 clinical data presentation

KEYNOTE-054 adjuvant melanoma slide deck providing information on study design, trial endpoints, efficacy and safety.

More information about KEYTRUDA® (pembrolizumab) in melanoma

Supporting documentation

GB-OOC-00301 | Date of Preparation: December 2020